Melkamu Getie‐Kebtie

Label‐free mass spectrometry‐based quantification of hemagglutinin and neuraminidase in influenza virus preparations and vaccines

M. Eichelberger, Melkamu Getie‐Kebtie, I. Sultana, 2012, Influenza and other respiratory viruses.

Potency under pressure: the impact of hydrostatic pressure on antigenic properties of influenza virus hemagglutinin

M. Eichelberger, Melkamu Getie‐Kebtie, I. Sultana, 2013, Influenza and other respiratory viruses.

Proteomics‐based characterization of hemagglutinins in different strains of influenza virus

M. Eichelberger, Melkamu Getie‐Kebtie, M. Alterman, 2009, Proteomics. Clinical applications.

Development of a protein marker panel for characterization of human induced pluripotent stem cells (hiPSCs) using global quantitative proteome analysis

Melkamu Getie‐Kebtie, M. Alterman, H. Malech, 2015, Stem cell research.

Proteomic approach for creation of the protein marker panels to control the quality of human induced pluripotent stem cells

Melkamu Getie‐Kebtie, M. Alterman, C. Grunseich, 2022, Current Topics in iPSCs Technology.

Label-free mass spectrometry-based relative quantification of proteins separated by one-dimensional gel electrophoresis.

M. Eichelberger, Melkamu Getie‐Kebtie, M. Alterman, 2011, Analytical biochemistry.

Stability of neuraminidase in inactivated influenza vaccines.

M. Eichelberger, Melkamu Getie‐Kebtie, I. Sultana, 2014, Vaccine.

Mass spectrometry-based proteomic analysis of human liver cytochrome(s) P450.

Melkamu Getie‐Kebtie, M. Alterman, K. Shrivas, 2013, Toxicology and applied pharmacology.